Cutaneous T cell lymphomas (CTCL) are rare lymphoproliferative diseases, which are frequently suspected to be of viral origin. As very few data were available concerning cutaneous T cell lymphomas in tropical Africa, we undertook a clinical, histopathological, immunological and viro-molecular study of patients with a clinical diagnosis of cutaneous lymphoma, in Bamako, Mali. While prior to this study, no case of CTCL had been reported in this country, 14 patients (five women, nine men; mean age 58 years) with a diagnosis of cutaneous lymphoma were seen over a period of 30 months (1992-1994) in the only dermatological department in Mali. Clinically, the most frequent pattern was an infiltrated erythrodermia similar to Sezary syndrome. Nodular lesions and/or plaques were rarely observed. All these cutaneous tumors were T cell lymphoproliferations, only one expressing the CD8 + antigen. A comprehensive analysis of all the available data permitted characterization of three cases of adult T cell leukemia/lymphoma (ATL) associated with HTLV-I (one definitive case, of leukemic type, with demonstration of clonal integration of HTLV-I proviral genome and two probable ATL cases), three cases of Sezary syndrome (SS), two cases of mycosis fungoides (MF) and five cases of pleomorphic cutaneous lymphoma. In one case, the differentiation between MF and pleomorphic cutaneous lymphoma could not be established. HTLV-I serological and/or molecular markers were restricted to the three ATL cases. From the unique definitive ATL case, a T cell line was established from culture of peripheral blood mononuclear cells and sequence analysis of the env gene and the U3-LTR region demonstrated that the virus present in this patient belonged to the cosmopolitan subtype A. Thus, we report here the first evidence of HTLV-I infection and associated ATL in Mali. This is the second ATL case described for the whole Sahelian region (one ATL of the lymphoma type was reported previously in a Mauritanian patient). Furthermore, we demonstrate that the main types of CTCL described in Europe and North America are also present in this African area and that the prevalence of these diseases is greatly underestimated in such regions. Furthermore, no association was observed between HTLV-I/II infection and SS, MF or pleomorphic cutaneous lymphoma in Mali in contrast to other studies.
Introduction
For many years, mycosis fungoides (MF), Sezary syndrome (SS) and related disorders such as Pagetoid reticulosis and lymphomatoid papulosis were the only well-defined types of cutaneous lymphomas. The introduction of immunohistochemical and gene rearrangement studies allowed new classifications of such cutaneous lymphoproliferative disorders. Updated Kiel classification 1, 2 or the recent REAL 3 were established for the classification of hematological lymphomas and seem to be less appropriate for cutaneous lymphomas. The Dutch Cutaneous Lymphoma Working Group recently published a specific classification for cutaneous T cell lymphomas (CTCL), based on both clinical and histopathological criteria. [4] [5] [6] [7] [8] [9] Such classification has been recently proposed by the European Organization for Research and Treatment of Cancer (EORTC). 10 CTCL have been frequently suspected to be of viral origin. [11] [12] [13] [14] Adult T cell leukemia/lymphoma (ATL), clearly linked etiologically with HTLV-I infection, shares clinical and histopathological features with MF/SS.
14 Thus, the smoldering form of ATL can present with slowly progressive cutaneous lesions and both entities are CD4-positive T lymphoproliferative disorders. 15 Some authors have shown by molecular means that deleted HTLV-I provirus, especially HTLV-I-related tax sequences, could be detected in patients' cells with CTCL such as MF and SS. 14, [16] [17] [18] These data remain controversial. 14, 19, 20 An etiological role of HTLV-I infection has also been suggested in other forms of CTCL such as pleomorphic large or small lymphomas, and CD30
+ large cell lymphomas. 21, 22 Epidemiological studies have demonstrated that the relative percentage of malignant lymphoproliferations varies widely according to geography, probably linked to different etiological factors, including viruses. 23 Thus, ATL associated with HTLV-I is highly prevalent in Southern Japan, whereas it is virtually absent in European countries. Burkitt's lymphoma associated with Epstein-Barr virus (EBV) is the major cause of childhood tumors in East Africa, whereas it is rare in the USA or in Europe other than in HIV-infected individuals.
Furthermore, data concerning CTCL in tropical Africa are virtually non-existent, due mainly to the paucity of dermatologists and of immunovirological facilities. The goal of the present study was to analyze the characteristics of cutaneous lymphoproliferative disorders as seen in Mali (a country of West Africa belonging to the Sahelian region) and also to investigate these patients for HTLV-I/II infection by serological and molecular means.
Materials and methods

Patients
All patients presenting during a 30 month period (June 1992-December 1994) at the Institut Marchoux (Bamako), the only dermatological clinic in Mali, with a clinical suspicion of a cutaneous lymphoma were included in this study. Mali is a land-locked Sahelian country with eight million inhabitants, the capital being Bamako. Blood samples and cutaneous biopsies were sent to the Pasteur Institute (Paris), where peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque. High molecular weight DNA was extracted from PBMC and cutaneous biopsies by a classical phenolchloroform method. During the same period, 115 out-and inpatients originating from the same dermatological department at the Institut Marchoux were serologically tested for HTLV-I/II infection.
Morphological and surface marker studies
Cell morphology was analyzed by light microscopy on MayGrü nwald-Giemsa-stained PBMC. The surface phenotype of the cells was determined by a standard method of indirect immunofluorescence and flow cytometric reading (Epics Profile II; Coulter, France), using a large panel of monoclonal antibodies (MoAbs), as previously described. 24 Histopathology of cutaneous biopsies Cutaneous material was obtained by punch or surgical biopsy, fixed in 10% buffered formalin and embedded in paraffin. The sections were stained with hematoxylin-eosin Giemsa and Gomori's silver impregnation. Immunohistochemistry, using a panel of Moabs recognizing T-and B-restricted antigens, was performed using the avidin-biotin complex (ABC) immunoperoxidase technique. [25] [26] [27] Independent histological examination was undertaken by two pathologists (MH and SF). Histological classification was performed according to the established diagnostic criteria used for primary T cell cutaneous lymphomas by the Dutch Cutaneous Lymphoma Working Group and the EORTC as described by Willemze et al. 6, 10 HTLV-I/II serological and molecular studies An indirect immunofluorescence assay (IFA), using an HTLV-I producing cell line (MT2) was initially used as a screening test to detect HTLV-I antibodies in serum and a Western blot assay (WB) (HTLV 2-3; Diagnostic Biotechnology, Singapore) was used for confirmation.
Polymerase chain reaction (PCR) was carried out on 1 g of genomic DNA, extracted from PBMC or cutaneous biopsy fragments, in a total volume of 100 l as previously described, using four primer sets specific for HTLV-I/II tax, pol and pX/LTR regions. 28, 29 Amplified DNA was size fractionated by 4% agarose gel electrophoresis and transferred overnight on a nylon membrane, then hybridized with a ␥ 32 P-dATP endlabeled internal corresponding probe. Nylon membranes were exposed at −80°C on a film (Hyperfilm MP; Amersham, Sweden) for 24 h and for 1 week. We used human ␤-globin gene specific primer pairs (268 bp) for all samples to verify the DNA integrity in each case. 29 The sensitivity of this HTLV-I/II PCR was estimated to be of 20-50 viral copies for 100 000 cells (0.7 g DNA).
PCR using specific TCR ␥ locus V-J junction region PCR amplification of T cell receptor (TCR) ␥ locus V-J junction sequences was performed, in three multiplex reactions, on 1 g of genomic DNA as previously described. 30 Samples were run on a 6% non-denaturing polyacrylamide gel and visualized with ethidium bromide.
Results
Clinical aspects
Fourteen patients were studied (Table 1) . They included five women and nine men, with a mean age of 58 years. All patients were black and originated from different regions of Mali.
Clinically, a 'typical MF' was rarely observed (only one case: No. 7); on the contrary, an erythrodermal 'SS-like' was frequently noticed (8/14: Nos 1, 4-6, 8, 9, 13, 14) ( Figure 1) . A 'nodular' pattern was observed in only two patients (Nos 10 and 11) (Figure 1 ). Two further cases presented with mixed patterns (Nos 3 and 14) (Figure 1 ). Another patient had an actinic reticuloid pattern, characterized by severe and persistent photosensitivity with erythema, oedema and 'leonine' thickening of the light-exposed skin (No. 12). Palmo-plantar keratosis was frequently observed (8/14), as was alopecia (6/14) and peripheral lymph node enlargement (12/14) . Splenic enlargement was rare (1/14) . A rapid outbreak of cutaneous lesions was observed in the three ATL patients. Three patients rapidly died (one ATL (No. 1) and two SS (Nos 4 and 6)). One patient was rapidly lost for follow-up (No. 12). Seven cases were treated with systemic corticosteroids (Nos 2, 3, 5, 8, 10, 11 and 13) with initial improvement but generally secondary relapse; three of these seven patients also received cyclophosphamide without evident benefit (Nos 3, 8 and 10); two of the seven died, the others were lost for follow-up. Three final patients were treated with topical corticosteroids (Nos 7, 9 and 14); one of them died (No. 14), the two others were lost for follow-up. Cutaneous lesions were histologically heterogeneous and consisted of a heavy dermal infiltrate with a majority of lymphocytes (medium and small). Epidermotropism was obvious in nine cases, especially in patients classified as MF or SS. Three cases were classified as typical MF (Nos 6, 7 and 8) (Figure 1) . A case of clinical and biological SS showed only few atypical cells in the epidermis, consistent however with the diagnosis of MF (No. 5). In another case of SS, no epidermotropism was observed and small/medium lymphocytes were clustered in the perivascular spaces and associated with a superficial macrophage infiltrate containing numerous leishmania. This case was classified as a pleomorphic lymphoma associated with a diffuse cutaneous leishmaniasis (leishmania major) (No. 4). In nine cases (Nos 1-3 and 9-14) (Figure 1) , the lesions were classified as pleomorphic lymphoma with small/medium cells in seven cases and medium/large cells in two cases. In one case (No. 9), the diagnosis of hematodermia was histopathologically certain, but no definite diagnosis between MF and pleomorphic CTCL could be proved because of a moderate epidermotropism. Lymph node histopatho- logical data were only available for one patient (No. 1), showing a pleomorphic T cell lymphoma as in the skin.
Cytological and immuno-histopathological features
Immunochemistry demonstrated the T phenotype (positivity of CD45 (UCHL1) and CD3) of the cutaneous lymphocytic infiltrate in all cases studied. Thus, none of the tumors were of B cell origin (negativity of CD20). CD30 positivity was found only in one ATL case with large cells (No. 2). CD8 positivity was evident in one case of small/medium cell pleomorphic CTCL (No. 12). In two cases (Nos 5 and 13), the infiltrate contained a few LMP-positive cells, suggesting the presence of the late EBV antigen.
Molecular and virological findings
TCR␥ gene rearrangement studies were available for 12 patients. All the samples were amplified by the specific primer pairs of the human ␤-globin gene, demonstrating the integrity of the DNA samples. A clonal population was found in both the skin and PBMC in only three cases, including 2/3 SS and 1/5 pleomorphic CTCL (Nos 4, 5 and 10). TCR␥ clonal bands had an identical size in cutaneous biopsies and PBMC in all three cases, reflecting the presence of the same lymphoid clone in PBMC and skin of the same patient. A clonal T cell population (sensitivity approximately 5%) was found only in the PBMC in three other cases (Nos 1, 6 and 12), including the third SS, 1/1 ATL tested and 1/5 pleomorphic CTCL and only in the skin in one MF patient (No. 7). No TCR␥ clonal rearrangement was found in other cases. The dermo-epidermal infiltration by pathological cells in TCR 'negative' skin biopsies was generally as massive as in 'positive' skin biopsies.
Three patients were HTLV-I-seropositive; two other patients' sera showed an indeterminate Western blot profile (Nos 6 and 8) (Table 1) . We searched by PCR for HTLV-I proviral sequences in the DNA extracted from cutaneous biopsies and/or PBMC (available for 12 cases), using specific HTLV-I pol, pX/LTR and gag primers: PBMC DNA amplification was positive only (with all the primers) for the single patient with ATL tested. Staging was not available for all the patients because of lack of histopathological (lymph node and bone marrow biopsies) and radiographic data. Concerning the two patients with ATL and whose DNA was lacking for molecular analysis, the use of 2 point-score classifications recently described by Levine et al 31 and Matutes et al 32 led us to the diagnosis of probable ATL for both cases (score of 5 and 6, respectively). Then, a comprehensive analysis of all the available results (Table 1) , based on the Dutch Cutaneous Lymphoma Working Group and EORTC classifications, led to the final diagnosis of: three cases of ATL (one definitive and two probable), and 11 primary cutaneous T cell lymphomas; three cases of SS, two cases of MF, one unclassified case of 'MF/pleomorphic CTCL' and five cases of pleomorphic CTCL.
Figure 2
Southern blot analysis performed as previously described. 23 
Discussion
Few data have been published on T cell lymphoproliferative disorders in intertropical Africa. 24, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] To our knowledge, this study represents the first series of cutaneous T cell lymphomas reported from tropical Africa and the Sahelian region. We demonstrate that all types of CTCL, including classic mycosis fungoides, Sezary syndrome, pleomorphic CTCL and acute or smoldering adult T cell leukemia/lymphoma are present in such a geographical area.
In the present series, clinical aspects were concordant with the typical description: MF/SS cases presenting with erythematous scaling plaques or infiltrated erythrodermia, and most pleomorphic CTCL cases presenting with papules or nodules sometimes ulcerated. Patients with ATL had variable clinical aspects: scaling plaques, disseminated papules or nodules, also erythrodermia. Histopathologically, these T cell cutaneous lymphoproliferations were pleomorphic, some having typical MF/SS lesions. Patients with ATL had a pleomorphic aspect with a dermal infiltrate composed of mainly small and medium-size T cells; it was of interest to note that the only case presenting with partially large cell dermal infiltrate was the only one who had a CD30 + phenotype. One case, clinically presenting as an actinic reticulosis and histopathologically as a CD8 + pleomorphic CTCL, had large granular lymphocytes (LGL) in his peripheral blood. The presence of this LGL proliferation could explain the positivity of the TCR␥ gene rearrangement in the PBMC since LGL (classically CD8 + ) usually demonstrate clonal TCR rearrangements despite their benign evolution. Thus a differential diagnosis between cutaneous pseudo-lymphoma 'actinic reticulosis-like' and a CTCL can be discussed for this case.
The presence of a clonal TCR rearrangement in the skin, or to a lesser extent in the blood, represents an argument in favor of a malignant process. [46] [47] [48] [49] Clonal TCR␥ gene rearrangement was detectable in the skin and/or the PBMC in 1/1 ATL, 3/3 SS, 1/2 MF, and strikingly only 2/6 pleomorphic CTCL (including one indeterminate MF/pCTCL). This may be due to partial infiltration by the malignant cells in some of the biopsies used for DNA extraction, since the PCR technique for TCR detection has a sensitivity of approximately 5%. 30 However, such results are similar to those of the literature especially for MF. 47 Regarding the pleomorphic CTCL, a clonal TCR positivity was found in only two cases of six but, to our knowledge, very few molecular data have been published on this rare form of CTCL. [47] [48] [49] Our series emphasizes the need for a comparison of clinical, histopathological, hematological, virological and molecular studies to make a proper diagnosis of CTCL, especially since in tropical areas, differential diagnosis between MF and SS on one hand and smoldering ATL on the other hand is sometimes very difficult.
The African continent represents a major endemic area for HTLV-I with an estimation of two to five million infected inhabitants. 50 The seroprevalence is about 0.5 to 1% in the adult population with a typical increase with age and in females. However, the distribution of HTLV-I in Africa is not ubiquitous, but is characterized by clusters of high endemic areas often located near to areas of very low seroprevalence. Such puzzling heterogeneity has been well described in Central Africa; 50, 51 however, very few data are available on HTLV-I and associated diseases in the West African and Sahelian countries. 24, 33, 34, 36, 38, 41, 42 The data presented in this study are, to our knowledge, the first evidence of HTLV-I infection and associated ATL in Mali. 41 In the neighboring country of Senegal, preliminary data indicate a seroprevalence in blood donors of around 0.7 to 1% with evidence of neurological and hematological-associated diseases. 42 Concerning ATL in tropical Africa, only rare cases with viro-immuno-molecular studies have been reported in the literature 24, 33, 38, 52 (Table 2) . A few cases of non-Hodgkin lymphomas and chronic lymphocytic leukemias have also been associated with HTLV-I based on serological data, 34, 36, 37 but in the absence of specific cytological and/or immuno-virological data, the etiological link between these lymphoproliferations and HTLV-I remains speculative. In our study, one typical acute ATL case with specific cutaneous T cell localizations, demonstrated HTLV-I clonal integration in the leukemic cells, which were shown to be mature activated T cells (CD4
+ ) with a clonal TCR rearrangement. In the other two, no DNA was available for viro-molecular studies but based on serological, cytological, and pathological analysis, ATL was highly probable.
Prior to this 30 month survey which was performed in only one dermatological center, no case of CTCL had been reported in Mali. This suggests that the prevalence of such diseases is greatly underestimated in African countries, 24, 34, 39, 40, 44 as has been the case in South American areas such as Brazil 53, 54 and French Guiana. 55 For ATL and SS, this under-reporting appears to be due mainly to the acute character of the disease, with patients dying before a diagnosis can be made, but also to the paucity of dermatologists and to the fact that HTLV-I serological confirmatory tests (Western blot), immuno-phenotyping and/or viro-molecular investigations are not readily available.
As seen above, there are marked similarities between the clinical and histopathological features of some types of ATL and other CTCL including SS, MF and CD30 anaplastic large cell CTCL. This led to a search for the presence of defective HTLV-I in post-thymic mature T lymphoproliferations. 12, 14 Several groups have thus demonstrated HTLV-I proviral fragments -mostly tax -in DNA extracted from PBMC and/or cutaneous lesions by PCR, in HTLV-I-seronegative SS and MF patients. 17, 18, [56] [57] [58] In Africa, HTLV-I has recently been isolated from a transformed T cell line spontaneously derived from PBMC of a seronegative Egyptian patient with MF. 35 In contrast, other groups failed to detect such HTLV-I sequences in similar patients. 19, 59 On the other hand, the presence of defective HTLV-I provirus was detected in four patients suffering from CD30 anaplastic large cell CTCL. 21 In the present study, all the CTCL other than ATL cases, were HTLV-I-seronegative and we were unable to detect any specific HTLV-I sequences by PCR in the DNA extracted from PBMC or cutaneous lesions of the SS, MF or pleomorphic CTCL.
In conclusion, in this study, we report the first evidence of HTLV-I infection and associated ATL in Mali, West Africa, demonstrate that the main types of CTCL described in Europe and North America are also present in tropical Africa and the Sahelian region, and suggest that the prevalence of these diseases is greatly underestimated in such regions. Furthermore, an association between HTLV-I/II infection and SS, MF or pleomorphic cutaneous lymphoma, could not be observed in our series.
